Table 2.
Factor | Progressors/Total | 3-y DFS (%) | p-value |
---|---|---|---|
T-stage | 0.99 | ||
T1-2 | 6/14 | 69 | |
T3-4 | 5/10 | 56 | |
Lymph Node Mets | 0.14 | ||
N0/N1 | 2/8 | 86 | |
N2 | 9/16 | 49 | |
Tumor Grade | 0.61 | ||
Low | 3/5 | 53 | |
High | 8/19 | 64 | |
Perineural Inv. | 0.29 | ||
Absent | 4/11 | 70 | |
Present | 7/13 | 55 | |
Age | 0.86 | ||
< 55 | 4/9 | 50 | |
> 55 | 7/15 | 71 | |
Gender | 0.28 | ||
Male | 6/16 | 72 | |
Female | 5/8 | 44 | |
Dose > 63 Gy | 0.81 | ||
Yes | 6/15 | 63 | |
No | 5/9 | 50 | |
TFHX | 0.17 | ||
Yes | 3/12 | 80 | |
No | 8/12 | 45 |